Atezolizumab with or without chemotherapy in metastatic urothelial cancer (IMvigor130): a multicentre, randomised, placebo-controlled phase 3 trial.

Galsky M., Arija J., Bamias A., Davis I., De S., Kikuchi E., ...More

Lancet (London, England), vol.395, pp.1547-1557, 2020 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 395
  • Publication Date: 2020
  • Doi Number: 10.1016/s0140-6736(20)30230-0
  • Title of Journal : Lancet (London, England)
  • Page Numbers: pp.1547-1557